TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

Phase IIa Study of SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma.

Manmeet S Ahluwalia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.